cyclopentane has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgartner, RA; Beaven, MA; Deramo, VA | 1 |
| Brunsing, RL; Prossnitz, ER | 1 |
2 other study(ies) available for cyclopentane and transforming growth factor beta
| Article | Year |
|---|---|
Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines.
Topics: Animals; Brefeldin A; Cyclopentanes; Dexamethasone; Enzyme Inhibitors; Gene Expression Regulation; Golgi Apparatus; Humans; Indoles; Leukemia, Basophilic, Acute; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Macrophage Activation; Macrophages; Maleimides; Mast Cells; Protein Kinase C; Rats; Signal Transduction; T-Lymphocytes; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Proliferation; Cyclopentanes; Extracellular Signal-Regulated MAP Kinases; Forkhead Transcription Factors; Green Fluorescent Proteins; Interferon-gamma; Interleukin-10; Interleukin-17; Interleukin-23; Interleukin-6; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nuclear Receptor Subfamily 1, Group F, Member 3; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Spleen; T-Lymphocyte Subsets; T-Lymphocytes; Th17 Cells; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2011 |